IL-2 activated killer cell activity is associated with the early phase of allograft rejection

Transplant Proc. 1991 Feb;23(1 Pt 1):597-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cytotoxicity, Immunologic
  • Dogs
  • Graft Rejection*
  • Interleukin-2 / pharmacology*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lung Transplantation / immunology*
  • Lymphocyte Activation*
  • Transplantation, Homologous

Substances

  • Interleukin-2